Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
Abstract In this study, we evaluated the consequences of reducing Galectin-1 (Gal-1) in the tumor micro-environment (TME) of glioblastoma multiforme (GBM), via nose-to-brain transport. Gal-1 is overexpressed in GBM and drives chemo- and immunotherapy resistance. To promote nose-to-brain transport, w...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2a7a658622cc4fa59a489055084f3169 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:2a7a658622cc4fa59a489055084f3169 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:2a7a658622cc4fa59a489055084f31692021-12-02T16:08:22ZSensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy10.1038/s41598-017-01279-12045-2322https://doaj.org/article/2a7a658622cc4fa59a489055084f31692017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01279-1https://doaj.org/toc/2045-2322Abstract In this study, we evaluated the consequences of reducing Galectin-1 (Gal-1) in the tumor micro-environment (TME) of glioblastoma multiforme (GBM), via nose-to-brain transport. Gal-1 is overexpressed in GBM and drives chemo- and immunotherapy resistance. To promote nose-to-brain transport, we designed siRNA targeting Gal-1 (siGal-1) loaded chitosan nanoparticles that silence Gal-1 in the TME. Intranasal siGal-1 delivery induces a remarkable switch in the TME composition, with reduced myeloid suppressor cells and regulatory T cells, and increased CD4+ and CD8+ T cells. Gal-1 knock-down reduces macrophages’ polarization switch from M1 (pro-inflammatory) to M2 (anti-inflammatory) during GBM progression. These changes are accompanied by normalization of the tumor vasculature and increased survival for tumor bearing mice. The combination of siGal-1 treatment with temozolomide or immunotherapy (dendritic cell vaccination and PD-1 blocking) displays synergistic effects, increasing the survival of tumor bearing mice. Moreover, we could confirm the role of Gal-1 on lymphocytes in GBM patients by matching the Gal-1 expression and their T cell signatures. These findings indicate that intranasal siGal-1 nanoparticle delivery could be a valuable adjuvant treatment to increase the efficiency of immune-checkpoint blockade and chemotherapy.Matthias Van WoenselThomas MathivetNathalie WauthozRémi RosièreAbhishek D. GargPatrizia AgostinisVéronique MathieuRobert KissFlorence LefrancLouis BoonJochen BelmansStefaan W. Van GoolHolger GerhardtKarim AmighiSteven De VleeschouwerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Matthias Van Woensel Thomas Mathivet Nathalie Wauthoz Rémi Rosière Abhishek D. Garg Patrizia Agostinis Véronique Mathieu Robert Kiss Florence Lefranc Louis Boon Jochen Belmans Stefaan W. Van Gool Holger Gerhardt Karim Amighi Steven De Vleeschouwer Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy |
| description |
Abstract In this study, we evaluated the consequences of reducing Galectin-1 (Gal-1) in the tumor micro-environment (TME) of glioblastoma multiforme (GBM), via nose-to-brain transport. Gal-1 is overexpressed in GBM and drives chemo- and immunotherapy resistance. To promote nose-to-brain transport, we designed siRNA targeting Gal-1 (siGal-1) loaded chitosan nanoparticles that silence Gal-1 in the TME. Intranasal siGal-1 delivery induces a remarkable switch in the TME composition, with reduced myeloid suppressor cells and regulatory T cells, and increased CD4+ and CD8+ T cells. Gal-1 knock-down reduces macrophages’ polarization switch from M1 (pro-inflammatory) to M2 (anti-inflammatory) during GBM progression. These changes are accompanied by normalization of the tumor vasculature and increased survival for tumor bearing mice. The combination of siGal-1 treatment with temozolomide or immunotherapy (dendritic cell vaccination and PD-1 blocking) displays synergistic effects, increasing the survival of tumor bearing mice. Moreover, we could confirm the role of Gal-1 on lymphocytes in GBM patients by matching the Gal-1 expression and their T cell signatures. These findings indicate that intranasal siGal-1 nanoparticle delivery could be a valuable adjuvant treatment to increase the efficiency of immune-checkpoint blockade and chemotherapy. |
| format |
article |
| author |
Matthias Van Woensel Thomas Mathivet Nathalie Wauthoz Rémi Rosière Abhishek D. Garg Patrizia Agostinis Véronique Mathieu Robert Kiss Florence Lefranc Louis Boon Jochen Belmans Stefaan W. Van Gool Holger Gerhardt Karim Amighi Steven De Vleeschouwer |
| author_facet |
Matthias Van Woensel Thomas Mathivet Nathalie Wauthoz Rémi Rosière Abhishek D. Garg Patrizia Agostinis Véronique Mathieu Robert Kiss Florence Lefranc Louis Boon Jochen Belmans Stefaan W. Van Gool Holger Gerhardt Karim Amighi Steven De Vleeschouwer |
| author_sort |
Matthias Van Woensel |
| title |
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy |
| title_short |
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy |
| title_full |
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy |
| title_fullStr |
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy |
| title_full_unstemmed |
Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy |
| title_sort |
sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by galectin-1 intranasal knock-down strategy |
| publisher |
Nature Portfolio |
| publishDate |
2017 |
| url |
https://doaj.org/article/2a7a658622cc4fa59a489055084f3169 |
| work_keys_str_mv |
AT matthiasvanwoensel sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT thomasmathivet sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT nathaliewauthoz sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT remirosiere sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT abhishekdgarg sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT patriziaagostinis sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT veroniquemathieu sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT robertkiss sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT florencelefranc sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT louisboon sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT jochenbelmans sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT stefaanwvangool sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT holgergerhardt sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT karimamighi sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy AT stevendevleeschouwer sensitizationofglioblastomatumormicroenvironmenttochemoandimmunotherapybygalectin1intranasalknockdownstrategy |
| _version_ |
1718384518708068352 |